Market Overview

Maxim Group Reiterates Buy on ARIAD Pharmaceuticals, Inc., Lowers PT to $24.00

Share:

Latest Ratings for ARIA

DateFirmActionFromTo
Jan 2017SunTrust Robinson HumphreyDowngradesBuyHold
Jan 2017BarclaysUpgradesUnderweightEqual-Weight
Jan 2017JefferiesDowngradesBuyHold

View More Analyst Ratings for ARIA
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ARIA)